Consolidated Statements of Shareholders' Equity - USD ($)		Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock Issued	Additional Paid-in Capital	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjustment	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Treasury stock
Beginning balance (in shares) at Dec. 31, 2018	[1]			415,700,000
Beginning balance at Dec. 31, 2018	[1]	$ 1,990,388,000		$ 42,000	$ 1,362,493,000		$ 627,853,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Class B Unit expense		(14,880,000)			(14,880,000)
Net income (loss)		9,710,000					9,710,000
Ending balance (in shares) at Dec. 31, 2019	[1]			415,700,000					0
Ending balance at Dec. 31, 2019	[1]	1,985,218,000		$ 42,000	1,347,613,000		637,563,000		$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Class B Unit expense		405,843,000			405,843,000
2020 Omnibus Incentive Plan (in shares)				31,250					13,087
2020 Omnibus Incentive Plan (in shares)				(31,250)					(13,087)
2020 Omnibus Incentive Plan (Note 15)		(94,000)			(211,000)				$ (117,000)
Effect of the Mergers (Note 4) (in shares)				128,806,148
Effect of the Mergers (Note 4)		(548,623,000)		$ 13,000	(548,636,000)
Private Placement Warrants and unvested founder shares (Note 10) (in shares)				(12,404,080)
Private Placement Warrants and unvested founder shares (Note 10)		(142,019,000)		$ (2,000)	(142,017,000)
PIPE Investment, net of costs (Note 4) (in shares)				132,050,000
PIPE Investment, net of costs (Note 4)		1,467,409,000		$ 13,000	1,467,396,000
Treasury stock purchases/ repurchase of common stock (in shares)									(9,094,876)
Treasury stock purchases / repurchase of common stock		(89,493,000)							$ (89,493,000)
Net income (loss)		$ (520,564,000)					(520,564,000)
Ending balance (in shares) at Dec. 31, 2020		655,075,355		664,183,318					(9,107,963)
Ending balance at Dec. 31, 2020		$ 2,557,865,000	$ (227,841,000)	$ 66,000	2,530,410,000	$ (233,874,000)	116,999,000	$ 6,033,000	$ (89,610,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
2020 Omnibus Incentive Plan (in shares)				1,272,862
2020 Omnibus Incentive Plan (in shares)				(1,272,862)
2020 Omnibus Incentive Plan (Note 15)		(16,355,000)		$ (1,000)	(16,354,000)
Tax withholding related to vesting of equity awards		(3,789,000)			(1,230,000)				$ (2,559,000)
Tax withholding related to vesting of equity awards (in shares)									(345,733)
Treasury stock purchases/ repurchase of common stock (in shares)									(17,663,710)
Treasury stock purchases / repurchase of common stock		(100,000,000)							$ (100,000,000)
Net income (loss)		$ 102,080,000					102,080,000
Ending balance (in shares) at Dec. 31, 2021		638,338,774		665,456,180					(27,117,406)
Ending balance at Dec. 31, 2021		$ 2,344,670,000		$ 67,000	$ 2,311,660,000		$ 225,112,000		$ (192,169,000)

[1] The shares of the Company's common stock, prior to the Transactions, have been retroactively restated as shares reflecting the exchange ratio established in the Transactions.